- Home
- NWPX vs BIOA Comparison
NWPX vs BIOA Comparison
Compare NWPX & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NWPX | BIOA |
|---|---|---|
| Founded | 1966 | 2015 |
| Country | United States | United States |
| Employees | N/A | 64 |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.9M | 856.3M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NWPX | BIOA |
|---|---|---|
| Price | $74.56 | $20.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $70.00 | $44.40 |
| AVG Volume (30 Days) | 77.1K | ★ 510.9K |
| Earning Date | 06-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.71 | N/A |
| EPS | ★ 3.56 | N/A |
| Revenue | ★ $526,003,000.00 | N/A |
| Revenue This Year | $5.78 | N/A |
| Revenue Next Year | $4.48 | $898.47 |
| P/E Ratio | $22.09 | ★ N/A |
| Revenue Growth | ★ 6.79 | N/A |
| 52 Week Low | $36.99 | $2.88 |
| 52 Week High | $83.12 | $24.00 |
Technical Indicators
Market Signals| Indicator | NWPX | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 50.91 |
| Support Level | $71.08 | $18.62 |
| Resistance Level | $77.43 | $21.50 |
| Average True Range (ATR) | 3.71 | 1.41 |
| MACD | -0.09 | -0.24 |
| Stochastic Oscillator | 29.98 | 31.74 |
Price Performance
Historical ComparisonAbout NWPX Northwest Pipe Company
NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.